BDRX - CIK 0001643918
The table below shows Biodexa Pharmaceuticals Plc's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2024 | Q2 2022 |
|---|---|---|
| Cash & equivalents | - | - |
| Short-term investments | - | - |
| Receivables | - | - |
| Inventory | - | - |
| Total current assets | - | - |
| Property, plant & equipment | - | - |
| Goodwill | - | - |
| Total assets | - | $9.68M |
| Accounts payable | - | - |
| Total current liabilities |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| Long-term debt | - | - |
| Total liabilities | $3.10M | $2.19M |
| Retained earnings | - | - |
| Total equity | - | - |